HER2 Support Group Forums - View Single Post - Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

News · 10-01-2018, 05:20 AM

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

More...

10-01-2018, 05:20 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,951	Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint. More...